Companies Cryptocurrencies
Fluidigm Corp
Fluidigm Corp
Exchange: Nasdaq Global Select
IPO Date: 10/02/2011
CEO: Mr. Stephen Linthwaite
Diagnostics & Research Healthcare 🔗
  • FLDM
  • 3.71
  • 286406816
    market cap
  • -0.27999997
If you bought

shares of Fluidigm Corp (FLDM) on
You would have made
Old Price $12 Current Price $12

Fluidigm Corp. is engaged in the development, manufacture and marketing of biotechnology tools fro life sciences research. The company is headquartered in South San Francisco, California and currently employs 535 full-time employees. The firm operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Address: 7000 Shoreline Ct Ste 100 South San Francisco CALIFORNIA 94080

Stay updated.